| Parameter | Score |
|---|---|
| 1. Scale | A |
| 2. Study Population | A |
| 3. Samples | B |
| 4. Measurand | B |
| 5. Pre-Analytical | A |
| 6. Replicate Analysis | B |
| 7. Steady State | C |
| 8. Outlier Analysis | C |
| 9. Normality | B |
| 10. Variance Homogeneity | C |
| 11. ANOVA | C |
| 12. CI | A |
| 13. No of Results | C |
| 14. Concentrations | A |
| 15. Total Score | C7,8,10,11,13 |
| Comment |
| Parameter | Score |
|---|---|
| Matrix | Serum |
| Measurand | Prostate specific antigen (PSA) - free |
| Unit | ng / mL |
| Overall Analytical Principle Method | Immunoassay; Other |
| Number of Subjects | 84 |
| Number of Subjects included in BV estimation | 84 |
| Ethinicity | Unknown |
| Age Mean / Median | 66.0 |
| Age Min | 53.0 |
| Age Max | 84.0 |
| Age SD | |
| Number of Males | 84 |
| Number of Females | 0 |
| State of Well Being |
Healthy (excl pregnant)
|
| Diseases | |
| Study Duration Length | 1 |
| Study Duration Units | Month |
| Sampling Intervals, e.g. X sample(s) per Interval Unit | 2 |
| Interval Units | Week |
| Sampling Times | Start Time:
End Time: |
| Number of Samples | |
| Average Number of Samples Used for BV Estimation | 3.0 |
| Average Number of Replicates | 1.0 |
| Estimates of CVi | 16.5 |
| Calculated Confidence Intervals of CVi | Lower: 14.71, Upper: 18.63 |
| Estimates of CVg | |
| Calculated Confidence Intervals of CVg | Lower: , Upper: |
| Analytical CV | 4.7 |
| Calculated Confidence Intervals of Analytical CV | Lower: 3.69, Upper: 6.49 |
| Measurand Mean | 0.6 |
| Measurand Min | 0.1 |
| Measurand Max | 1.1 |
| Measurand SD |